chr2-74498046-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000377566.9(LBX2):c.478G>A(p.Glu160Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000089 in 1,461,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000377566.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LBX2 | NM_001282430.2 | c.478G>A | p.Glu160Lys | missense_variant | 2/2 | ENST00000377566.9 | NP_001269359.1 | |
LBX2 | NM_001009812.2 | c.466G>A | p.Glu156Lys | missense_variant | 2/2 | NP_001009812.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LBX2 | ENST00000377566.9 | c.478G>A | p.Glu160Lys | missense_variant | 2/2 | 1 | NM_001282430.2 | ENSP00000366789 | P1 | |
LBX2 | ENST00000460508.3 | c.466G>A | p.Glu156Lys | missense_variant | 2/2 | 1 | ENSP00000417116 | |||
LBX2 | ENST00000550249.2 | n.772G>A | non_coding_transcript_exon_variant | 3/3 | 1 | |||||
LBX2 | ENST00000341396.2 | c.*123G>A | 3_prime_UTR_variant | 2/2 | 3 | ENSP00000450229 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250434Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135546
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1461270Hom.: 0 Cov.: 37 AF XY: 0.00000963 AC XY: 7AN XY: 726952
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2024 | The c.466G>A (p.E156K) alteration is located in exon 2 (coding exon 2) of the LBX2 gene. This alteration results from a G to A substitution at nucleotide position 466, causing the glutamic acid (E) at amino acid position 156 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at